Company Overview: Inovio

Industry News

21 Sep

Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies

PLYMOUTH MEETING, Pa., Sept. 21, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced that the development of its DNA-based monoclonal antibody program received a boost from two peer-reviewed scientific papers that demonstrate their impact on prostate tumors and in preventing infection from a pneumonia-causing bacteria in preclinical...

Read more

11 Sep

Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In Patients with Recurrent Prostate Cancer

PLYMOUTH MEETING, Pa., Sept. 11, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO), today announced that an interim data analysis showed that its INO-5150 cancer immunotherapy product generated antigen-specific CD8+ killer T cell responses measured in peripheral blood from subjects with biochemically recurrent prostate cancer. The immunology results demonstrate...

Read more

23 Aug

Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences

PLYMOUTH MEETING, Pa., Aug. 23, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced that the Company will participate in the following upcoming investment conferences: Citi’s 12th Annual Biotech Conference Panel Discussion: I/O Beyond PD-1: Opportunities & Challenges Dr. J. Joseph Kim, President & CEO 3:00 PM ET, September...

Read more

9 Aug

Inovio Pharmaceuticals Reports 2017 Second Quarter Financial Results

PLYMOUTH MEETING, Pa., Aug. 08, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today reported financial results for the quarter ended June 30, 2017. Total revenue was $20.4 million for the three months ended June 30, 2017, compared to $6.2 million for the same period in 2016. Total operating...

Read more

18 Jul

Inovio Announces Proposed Public Offering of Common Stock

PLYMOUTH MEETING, Pa., July 18, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced that it intends to offer and sell $75.0 million of shares of its common stock in an underwritten public offering.  Inovio expects to grant the underwriters an option to purchase up to an additional...

Read more

28 Jun

Inovio Announces Leadership Appointments

PLYMOUTH MEETING, Pa., June 28, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (INO) today announced leadership appointments to support its growth and expanding strategic and operational initiatives. Inovio promoted Dr. Keiko Simon to Vice President, Alliance and Program Management and Jeffrey C. Richardson to Vice President, Strategic Relations. Dr....

Read more

Page 1 of 1312345...10...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address